GPBAR1 and dermatitis: Previous studies have reported that BAs can exacerbate skin inflammation by activating G-protein bile acid-coupled receptor 5 (TGR5) and sphingosine-1-phosphate (S1P) receptor 2 (S1PR2) in the skin (33).